Recap: Caribou Biosciences Q2 Earnings

  Caribou Biosciences (NASDAQ:CRBU) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

 

Caribou Biosciences (NASDAQ:CRBU) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Caribou Biosciences missed estimated earnings by 22.22%, reporting an EPS of $-0.44 versus an estimate of $-0.36.

Revenue was up $2.72 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 9.3% increase in the share price the next day.

 

Listen to the earnings announcement yourself by clicking here.

To track all earnings releases for Caribou Biosciences visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance

Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth initiatives, with profit up 12.2% Y/Y and adjusted EPS at $10.64. Medicaid membership decline offset by commercial and ACA enrollment.

ELV